Pregnancy-related hypertension: a cardiovascular risk situation;Hypertension artérielle de la grossesse : une situation à risque cardiovasculaire

Presse Medicale

Volumn 38, Issue 4, 2009, Pages 600-608

  Mounier Vehier, Claire ^a   Delsart, Pascal ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA METHYLDOPAMINE; ANTITHROMBOCYTIC AGENT; ATENOLOL; CLONIDINE; LABETALOL; MAGNESIUM SULFATE; NICARDIPINE; NITRIATE; PINDOLOL; PRAZOSIN; SODIUM NITRATE; UNCLASSIFIED DRUG;

AMBULATORY MONITORING; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC DISEASE; CLINICAL FEATURE; CONVULSION; DIASTOLIC BLOOD PRESSURE; ENDOTHELIUM; FETUS DEATH; FETUS GROWTH; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; INTRAUTERINE GROWTH RETARDATION; ISCHEMIA; LACTATION; MATERNAL HYPERTENSION; METABOLIC SYNDROME X; PLACENTA PERFUSION; PREECLAMPSIA; PREGNANCY; REPRODUCTION; SELF MONITORING; SHORT SURVEY; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT INDICATION; TROPHOBLAST; WHITE COAT HYPERTENSION;

EID: 63649090033     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.11.018     Document Type: Short Survey

References (22)

1. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. Management of arterial hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: The Task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25 (2007) 1105-1187
2. Report of the Canadian Hypertension Society consensus conference: definitions, evaluation and classification of hypertensive disorders in pregnancy; non pharmacologic treatment and prevention of hypertensive disorders in pregnancy; pharmacologic treatment of hypertensive disorders in pregnancy. Can Med Asso 1997; 157:907-1254.
3. Hypertension in pregnancy: recommendations for diagnosis and treatment. European Society of Hypertension Scientific Newsletter: update on hypertension management 2000; 1:No 2. http://www.eshonline.org.
4. Sibai B.M. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102 (2003) 181-192
5. Harskamp R.E., and Zeeman G.G. Preeclampsia: at risk for remote cardiovascular disease. Am J Med Sci 334 (2007) 291-295
6. Newstead J., von Dadelszen P., and Magee L.A. Preeclampsia and future cardiovascular risk. Expert Rev Cardiovasc Ther 5 (2007) 283-294
7. Ray J.G., Vermeulen M.J., Schull M.J., and Redelmeier D.A. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 366 (2005) 1797-1803
8. Brown D.W., Dueker N., Jamieson D.J., Cole J.W., Wozniak M.A., Stern B.J., et al. Preeclampsia and the risk of ischemic stroke among young women: results from the Stroke prevention in young women study. Stroke 37 (2006) 1055-1059
9. Manten G.T., Sikkema M.J., Voorbij H.A., Visser G.H., Bruinse H.W., and Franx A. Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens Pregnancy 26 (2007) 39-50
10. Berends A.L., de Groot C.J., Sijbrands E.J., Sie M.P., Benneheij S.H., Pal R., et al. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension 51 (2008) 1034-1041
11. Kaaja R.J., and Greer I.A. Manifestations of chronic disease during pregnancy. JAMA 294 (2005) 2751-2757
12. Silva L.M., Coolman M., Steegers E.A., Jaddoe V.W., Moll H.A., Hofman A., et al. Low socioeconomic status is a risk factor for preeclampsia: the Generation R Study. J Hypertens 26 (2008) 1200-1208
13. Zhou Y., Fisher S.J., Janatpour M., Genbacev O., Dejana E., Wheelock M., et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion ?. J Clin Invest 99 (1997) 2139-2151
14. Parham P. NK cells and trophoblasts: partners in pregnancy. J Exp Med 200 (2004) 951-955
15. Ferguson J.H., Blake L., and Shaar C.J. Ambulatory blood pressure monitoring during pregnancy. Establishment of standards of normalcy. Am J Hypertens 7 (1994) 838-843
16. Denolle T., Daniel J.C., Calvez C., Ottavioli J.N., Esnault V., and Herpin D. Home blood pressure during normal pregnancy. Am J Hypertens 18 (2005) 1178-1180
17. Hermida R.C., Ayala D.E., Mojón A., Fernández J.R., Alonso I., Aguilar M.F., et al. Differences in circadian blood pressure variability during gestation between healthy and complicated pregnancies. Am J Hypertens 16 (2003) 200-208
18. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., et al. Circulating Angiogenic Factors and the Risk of Preeclampsia. N Engl J Med 350 (2004) 672-683
19. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
20. Brosens J., Pijnenborg A., Robert B., and Brosens I. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: A review of the literature. AJOG Reviews. Am J Obstet and Gynecol 187 (2002) 1416-1423
21. Coomarasamy A., Honest H., Papaioannou S., Gee H., and Khan K.S. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. BMJ 326 (2003) 845-851
22. Leitich H., Egarter C., Husslein P., Kaider A., and Schemper M. A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaecol 104 (1997) 450-459